Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial
Zhou J., Williams C., STAPLIN N., Judge P., Mayne K., Agrawal N., ARIMOTO R., Green J., Cherney D., Tuttle K., LEAL J., CLARKE P., EMBERSON J., PREISS D., Wanner C., LANDRAY M., Baigent C., HAYNES R., HERRINGTON W., MIHAYLOVA B.